Teladoc Health (TDOC) Q3 2026 earnings — TrendMatrix coverage

Adjusted EPS

-$0.12

Estimate

-$0.19

Surprise

+36.5%

Score today

4.1/10

Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.

Teladoc Health (TDOC) reported a narrower loss than forecast — adjusted EPS of -$0.12 against the -$0.19 estimate (a 36.5% beat on a still-unprofitable quarter).

• Huntington Ingalls, Crocs, Carvana, Insmed And Other Big Stocks Moving Higher On Thursday — benzinga, 2026-10-29
• Stifel Maintains Hold on Teladoc Health, Raises Price Target to $6.5 — benzinga, 2026-10-29
• 12 Health Care Stocks Moving In Thursday's Pre-Market Session — benzinga, 2026-10-29

TrendMatrix currently rates TDOC Sell at 4.1/10; no pre/post engine snapshot brackets this report.

4 of the last 4 quarters beat the estimate; this quarter's +36.5% surprise compares with a +31.5% four-quarter average.

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current price

$8.54

Stop

$7.94

Model outputs from TrendMatrix’s engine as of 2026-10-29 — shown for context, not personalized investment advice.

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry

Health Information Services

Market cap

$1.25B

P/E (fwd)

-9.5

52-week range

$4.40–$9.89

Off 52-week high

13.6%

RSI (14)

85

Volume vs avg

1.48×

Score today

4.1/10